![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2019
Fleischmann, Daniel Felix; Jenn, Johanna; Corradini, Stefanie; Ruf, Viktoria; Herms, Jochen; Forbrig, Robert; Unterrainer, Marcus; Thon, Niklas; Kreth, Friedrich Wilhelm; Belka, Claus und Niyazi, Maximilian
(2019):
Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma.
In: Radiotherapy and Oncology, Bd. 138: S. 99-105
2017
Thon, Niklas; Thorsteinsdottir, Jun; Eigenbrod, Sabina; Schüller, Ulrich; Lutz, Jürgen; Kreth, Simone; Belka, Claus; Tonn, Jörg-Christian; Niyazi, Maximilian und Kreth, Friedrich Wilhelm
(2017):
Outcome in unresectable glioblastoma: MGMT promoter methylation makes the difference.
In: Journal of Neurology, Bd. 264, Nr. 2: S. 350-358
2016
Kunz, Mathias; Nachbichler, Silke B.; Ertl, Lorenz; Fesl, Gunther; Egensperger, Rupert; Niyazi, Maximilian; Schmid, Irene; Tonn, Jörg Christian; Peraud, Aurelia und Kreth, Friedrich Wilhelm
(2016):
Early treatment of complex located pediatric low-grade gliomas using iodine-125 brachytherapy alone or in combination with microsurgery.
In: Cancer Medicine, Bd. 5, Nr. 3: S. 442-453
[PDF, 1MB]
Schnell, Oliver; Thorsteinsdottir, Jun; Fleischmann, Daniel Felix; Lenski, Markus; Abenhardt, Wolfgang; Giese, Armin; Tonn, Jörg-Christian; Belka, Claus; Kreth, Friedrich Wilhelm und Niyazi, Maximilian
(2016):
Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma.
In: Journal of Neuro-Oncology, Bd. 130, Nr. 3: S. 591-599